# FDA Inspection 556264 - Shenzhen Hepalink Pharmaceutical Co., Ltd. - November 26, 2008

Source: https://www.globalkeysolutions.net/records/fda_inspections/shenzhen-hepalink-pharmaceutical-co-ltd/7a811c96-3433-46e5-a91e-c82ead58c94e
Source feed: FDA_Inspections

> FDA Inspection 556264 for Shenzhen Hepalink Pharmaceutical Co., Ltd. on November 26, 2008. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 556264
- Company Name: Shenzhen Hepalink Pharmaceutical Co., Ltd.
- Inspection Date: 2008-11-26
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1134048 - 2020-01-13](https://www.globalkeysolutions.net/records/fda_inspections/shenzhen-hepalink-pharmaceutical-co-ltd/02a8fd3c-02ce-436c-9872-720da3a52401)
- [FDA Inspection 988107 - 2016-06-16](https://www.globalkeysolutions.net/records/fda_inspections/shenzhen-hepalink-pharmaceutical-co-ltd/d2a8f6cb-fd38-4555-b91e-573a1d8a325b)
- [FDA Inspection 823038 - 2013-01-15](https://www.globalkeysolutions.net/records/fda_inspections/shenzhen-hepalink-pharmaceutical-co-ltd/2cfc22b6-12ae-415b-87c2-e7d2bb7ecec2)
- [FDA Inspection 717785 - 2011-01-27](https://www.globalkeysolutions.net/records/fda_inspections/shenzhen-hepalink-pharmaceutical-co-ltd/0ce8ca70-d390-462a-b0a8-c2aff3a4a3c4)

Company: https://www.globalkeysolutions.net/companies/shenzhen-hepalink-pharmaceutical-co-ltd/73ab214e-7ba7-4484-bce3-4bf799bfa729

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c